Cinnamaldehyde induces fat cell-autonomous thermogenesis and metabolic reprogramming

• Published in: Metabolism, clinical and experimental Vol. 77; pp. 58 - 64
• Main Authors: Jiang, Juan, Emont, Margo P., Jun, Heejin, Qiao, Xiaona, Liao, Jiling, Kim, Dong-il, Wu, Jun
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.12.2017
• Subjects: Acrolein - analogs & derivatives; Acrolein - pharmacology; Adipocytes, Brown - physiology; Animals; Cinnamaldehyde; Cyclic AMP-Dependent Protein Kinases - drug effects; Cyclic AMP-Dependent Protein Kinases - metabolism; Flavoring Agents - pharmacology; Humans; Mice; Obesity; Obesity - drug therapy; Obesity - metabolism; Subcutaneous adipocytes; Thermogenesis; Thermogenesis - drug effects; Obesity; Cinnamaldehyde; Thermogenesis; Subcutaneous adipocytes; ROS; hASC; CA; BMI
• ISSN: 0026-0495; 1532-8600
• DOI: 10.1016/j.metabol.2017.08.006

Cinnamaldehyde (CA) is a food compound that has previously been observed to be protective against obesity and hyperglycemia in mouse models. In this study, we aimed to elucidate the mechanisms behind this protective effect by assessing the cell-autonomous response of primary adipocytes to CA treatment. Primary murine adipocytes were treated with CA and thermogenic and metabolic responses were assessed after both acute and chronic treatments. Human adipose stem cells were differentiated and treated with CA to assess whether the CA-mediated signaling is conserved in humans. CA significantly activated PKA signaling, increased expression levels of thermogenic genes and induced phosphorylation of HSL and PLIN1 in murine primary adipocytes. Inhibition of PKA or p38 MAPK enzymatic activity markedly inhibited the CA-induced thermogenic response. In addition, chronic CA treatment regulates metabolic reprogramming, which was partially diminished in FGF21KO adipocytes. Importantly, both acute and chronic effects of CA were observed in human adipose stem cells isolated from multiple donors of different ethnicities and ages and with a variety of body mass indexes (BMI). CA activates thermogenic and metabolic responses in mouse and human primary subcutaneous adipocytes in a cell-autonomous manner, giving a mechanistic explanation for the anti-obesity effects of CA observed previously and further supporting its potential metabolic benefits on humans. Given the wide usage of cinnamon in the food industry, the notion that this popular food additive, instead of a drug, may activate thermogenesis, could ultimately lead to therapeutic strategies against obesity that are much better adhered to by participants.